Subscribe Register Login
Sunday, June 17, 2018, 5:27 p.m.

This exclusive story is reserved for our subscribers.

Support independent journalism by subscribing to the Arkansas Democrat-Gazette.

Subscribe now to continue reading.

Jury hears of drugs’ diabetes risk

Testimony on Friday from a defense expert on endocrinology closed out the 10th day of the state’s Medicaid fraud lawsuit against Johnson & Johnson over its Risperdal medication, with both sides saying the trial is winding down.

Click here to login or subscribe below.

Home Delivery
& Online
Online Only
Get Started Get Started
Breaking News
Newspaper Content Online
Smartphone Access
Tablet App (iPad) Access
Home Delivery
Sunday Comics, Ad Inserts, Coupons